Actively Recruiting

Phase Not Applicable
Age: 19Years - 99Years
All Genders
Healthy Volunteers
ID03195556

Augmentation of Limb Perfusion With Contrast Ultrasound

Led by Oregon Health and Science University · Updated on 2018-08-23

30

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how ultrasound imaging combined with microbubble contrast agents can improve blood flow to the limbs, particularly in people with peripheral artery disease (PAD). Previous studies showed that high power contrast-enhanced ultrasound could nearly double limb perfusion, but those studies focused on imaging rather than treatment. This study aims to measure how much limb blood flow can be increased using specific therapeutic ultrasound settings that remain within FDA-approved safety limits. Participants receive a 15-minute high-power ultrasound therapy with intermittent ultrasound bursts and an intravenous infusion of microbubbles. This treatment is followed by low-power contrast ultrasound imaging to measure blood flow changes. The study includes two groups: healthy subjects and those with PAD. Measurements such as the ankle-brachial index (ABI) and toe-brachial index (TBI) are taken before and after treatment to evaluate perfusion changes. Participants will undergo blood flow assessments at 10 and 60 minutes after the ultrasound therapy to monitor treatment effects. The research team evaluates changes in limb perfusion using ultrasound imaging and clinical measurements. The study is non-randomized and does not involve blinding. Participation involves intravenous microbubble infusion, ultrasound procedures, and clinical assessments to track blood flow improvements over a short period.

CONDITIONS

Brief Title

Augmentation of Limb Perfusion With Contrast Ultrasound

Who Can Participate

Age: 19Years - 99Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • For PAD subjects: known history of unilateral or bilateral peripheral artery disease diagnosed by reduced ankle-brachial index or angiography
  • Rutherford symptom class of 4-6 for PAD subjects
Not Eligible

You will not qualify if you...

  • Major medical illness affecting the limb other than PAD, including muscle disease, blood diseases influencing flow or rheology, severe heart failure (NYHA class IV or LVEF <30%)
  • Pregnant or lactating females
  • Hypersensitivity to any ultrasound contrast agent
  • Known atrial septal defect or large right to left shunt
  • Hemodynamic instability (hypotension with systolic BP <90 mm Hg, need for vasopressors)
  • Evidence of ongoing myocardial ischemia
  • For normal controls, any known structural non-arrhythmic cardiovascular disease such as coronary artery disease, heart failure, or moderate or greater valve disease

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Implementation

Duration - 15 minutes

Participants receive high-power ultrasound cavitation therapy with intermittent ultrasound and intravenous infusion of microbubbles to augment limb perfusion.

1 treatment visit (in-person)

Monitoring

Duration - Up to 60 minutes after treatment

Participants have blood flow measurements taken before and after the ultrasound therapy to assess changes in limb perfusion.

1 follow-up visit with assessments at 10 and 60 minutes post-therapy

Trial Site Locations

Total: 1 location

1

OHSU

Portland, Oregon, United States, 97239

Actively Recruiting

Loading map...

Research Team

J

Jonathan R Lindner, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A ProspeCtive mUlticenteR Investigation on RENzar Stent Safe...

Peripheral Arterial Disease

Actively Recruiting

1 location

A Longitudinal, Real World, Observational Registry of Chroni...

Diabetic Foot

Actively Recruiting

1 location

An RCT Evaluating the Safety and Efficacy of the Endovascula...

Peripheral Arterial Disease

Actively Recruiting

13 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial